Anthropic’s Claude found a new CRISPR-like gene-editing mechanism in just 21 hours using 950 autonomous agents, marking a major milestone for AI-driven biological discovery.
Stanford Medicine’s virtual biotech company uses 37,000 AI agents to design a lung cancer therapy that later succeeded in clinical trials, showing AI can replicate the full drug development pipeline.
Anthropic’s Claude AI independently designed functional proteins for 14 out of 15 targets, hitting a 26.8% overall success rate that doubles or triples the industry standard. It even succeeded where human experts had previously failed.